When was Endra Life Sciences founded?

Endra Life Sciences was founded in 2007 and raised its 1st funding round 7 years after it was founded.

Where is Endra Life Sciences located?

Endra Life Sciences is headquartered in Ann Arbor, United States.

Who is the current CEO of Endra Life Sciences?

Francois Michelon of Endra Life Sciences.

How many employees does Endra Life Sciences have?

As of Sep 30, 2026, the latest employee count at Endra Life Sciences is 18.

Is Endra Life Sciences a funded company?

Endra Life Sciences is a funded company, having raised a total of $287K across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 25, 2014.

When was the latest funding round of Endra Life Sciences?

Endra Life Sciences' latest funding was a $***** Post IPO round on Oct 10, 2025, with participation from 0 investor. Its primary sector is Gastroenterology. In United States, the Gastroenterology sector has seen $978M in funding in 2026 to date.

Where does Endra Life Sciences rank among its competitors?

Endra Life Sciences ranks 1st amongst 3 active competitors, only 1 of which is funded. Endra Life Sciences, which secured $14.4M in Oct, 2025.

Endra Life Sciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of ultrasound imaging technology for liver disease detection. The company offers Thermo-acoustic enhanced ultrasound (TAEUS) that uses radio frequency and ultrasound waves for deep tissue imaging and to measure fat in the liver which is the cause of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).

Website: endrainc.com
Social
Email ID: *****@endrainc.com
Phone Number: +1 **********

Key Metrics

Founded Year

2007

Location

Ann Arbor, United States

Stage

Public

Total Funding

$287K in 5 rounds

Latest Funding Round

Post IPO, Oct 10, 2025, $*****

Investors

TRITON FUNDS & 1 more

Ranked

1^st among 3 active competitors

Employee Count

18 as on Sep 30, 2026

Investment & Acquisitions

Amelia Virtual Care

Similar Companies

Oncoustics & 1 more

Exit Details

Public

View Endra Life Sciences' full profile

Endra Life Sciences is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
ENDRA Life Sciences GmbH CIN: HRB119904 , Germany, Active	Jul 29, 2020	-	-
ENDRA LIFE SCIENCES INC. CIN: 4370875 , United States, Active	Jul 17, 2007	-	21 (As on Dec 31, 2022)	-

Endra Life Sciences got listed on May 09, 2017.

Click here to take a look at Endra Life Sciences's IPO in detail

Endra Life Sciences has raised a total funding of $287K over 5 rounds. Its first funding round was on Mar 25, 2014. Endra Life Sciences has 2 institutional investors.

Here is the list of recent funding rounds of Endra Life Sciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 10, 2025	4031168	Post IPO	4313275	6759640	1400250	3888117
Dec 20, 2019	2945057	Post IPO	4945437	1818292	8006198	4436508
Jul 29, 2019	3120806	Post IPO	4995845	5728451	7016315	4767688

Access funding benchmarks and valuations. Sign up today!

View details of Endra Life Sciences's funding rounds and investors

Endra Life Sciences' employee count trend

Endra Life Sciences has 18 employees as of Sep 26. Here is Endra Life Sciences's employee count trend over the years:

Employee count trend for Endra Life Sciences

Uncover Endra Life Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Endra Life Sciences include Oncoustics and Liver Scan. Here is the list of Top 10 competitors of Endra Life Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Endra Life Sciences 2007, Ann Arbor (United States), Public	Developer of ultrasound imaging technology for liver disease detection	$287K	TRITON FUNDS, Ascendiant Capital Markets	52/100
2nd	Oncoustics 2017, Toronto (Canada), Seed	AI-powered ultrasound solutions for non-invasive disease detection, focusing initially on liver conditions	$5.5M	Creative Ventures, Saltagen Ventures & 8 others	46/100
3rd	Liver Scan Edinburgh (United Kingdom), Unfunded	Provider of non-invasive ultrasound examinations to assess liver health status	-	-	16/100